Ultrasound-guided Continuous Adductor Canal Block for Analgesia After Total Knee Replacement: Comparison of Short-axis and Long-axis Techniques

NCT02799797 | Completed

• 1 other identifier: cuixulei1
• Study Type: interventional
• Target: 62
• Locations: 1 country
• Sites: 1

Brief Summary

This study compares the long-axis and short-axis technique of continues adductor canal block for total knee replacement surgery. Half participants will receive long-axis catheterization, while the other half will receive short-axis catheterization.

Conditions

Total Knee Arthroplasty; Analgesia; Nerve Block

Keywords

adductor canal block

Outcome Measures

Primary Outcomes (1)

• the strength of quadriceps femoris

  strength of quadriceps femoris measured on a Lovett muscle strength rating-scale within 48 hours after surgery

  within 48hours after surgery

Secondary Outcomes (8)

• postoperative nausea and vomiting score

  0-2, 2-4, 4-8, 8-24, 24-48 hours postoperative

• ambulation time

  within the 7 days after surgery

• quality of recovery

  3days and 7days after surgery

• complications

  within the 7 days after surgery

• the strength of quadriceps femoris

  0,2,4,8,24,48 hours postoperative

Study Arms (2)

short axis (SAX) placement of adductor canal catheters

ACTIVE COMPARATOR

Procedure: Ultrasound guided short axis (SAX) placement of adductor canal catheters Philip CX50 ultrasound scanner guided insertion of a PAJUNK Contiplex S catheter along the short axis of the middle part of adductor canal

Procedure: ultrasound guided short axis placement of adductor canal catheter; Device: Philip CX 50 Ultrasound Scanner; Device: PAJUNK Contiplex S Catheter; Drug: Ropivocaine; Drug: rescue sulfentanil given postoperatively as PICA

long axis (LAX) placement of adductor canal catheters

EXPERIMENTAL

Procedure: Ultrasound guided long axis (LAX) placement of adductor canal catheters Philip CX50 ultrasound scanner guided insertion of a catheter along the long axis of the middle part of adductor canal

Procedure: ultrasound guided long axis placement of adductor canal catheter; Device: Philip CX 50 Ultrasound Scanner; Device: PAJUNK Contiplex S Catheter; Drug: Ropivocaine; Drug: rescue sulfentanil given postoperatively as PICA

Interventions

ultrasound guided long axis placement of adductor canal catheter PROCEDURE

The long axis of the ultrasound probe is placed parallel to the long axis of the adductor canal while scanning, and the catheter is placed along the long axis of the canal using an in-plane approach

long axis (LAX) placement of adductor canal catheters

ultrasound guided short axis placement of adductor canal catheter PROCEDURE

The long axis of the ultrasound probe is placed vertical to the long axis of the adductor canal while scanning, and the catheter is placed along the short axis of the canal using an in-plane approach

short axis (SAX) placement of adductor canal catheters

Philip CX 50 Ultrasound Scanner DEVICE

The linear (C5-12) probe of Philip CX 50 Ultrasound Scanner is used for scanning

long axis (LAX) placement of adductor canal catheters; short axis (SAX) placement of adductor canal catheters

PAJUNK Contiplex S Catheter DEVICE

long axis (LAX) placement of adductor canal catheters; short axis (SAX) placement of adductor canal catheters

Ropivocaine DRUG

0.2% ropivacaine 10ml is given as loading dose. Following that, 0.2% ropivacaine 5ml/h is given as maintenance dose.

long axis (LAX) placement of adductor canal catheters; short axis (SAX) placement of adductor canal catheters

rescue sulfentanil given postoperatively as PICA DRUG

bolus: 2mg, lock time: 10min, 1h limitation: 8mg

long axis (LAX) placement of adductor canal catheters; short axis (SAX) placement of adductor canal catheters

Eligibility Criteria

• Age: 18 Years - 80 Years
• Sex: all
• Healthy Volunteers: No
• Age Groups: Adult (18-64), Older Adult (65+)

You may qualify if:

• years
• Knee-arthroscopy
• Written consent
• ASA I-III
• BMI 19-35

You may not qualify if:

• Unable to communicate with the investigators (e.g., a language barrier or a neuropsychiatric disorder).
• coagulopathy or on anticoagulant medication
• Allergic reactions toward drugs used in the trial
• History of substance abuse
• Infection at injection site
• Can not be mobilised to 5 meters of walk pre-surgery

Sponsors & Collaborators

• Cui Xulei: lead
• Medical Consulting Center: collaborator

Study Sites (1)

Xulei CUI

Beijing, Beijing Municipality, 100730, China

Location

MeSH Terms

Conditions

Agnosia

Condition Hierarchy (Ancestors)

Perceptual Disorders; Neurobehavioral Manifestations; Neurologic Manifestations; Nervous System Diseases; Signs and Symptoms; Pathological Conditions, Signs and Symptoms

Study Officials

• Yuguang Huang, MD

  Peking Union Medical College Hospital

  STUDY CHAIR

Study Design

• Study Type: interventional
• Phase: not applicable
• Allocation: RANDOMIZED
• Masking: TRIPLE
• Who Masked: CARE PROVIDER, INVESTIGATOR, OUTCOMES ASSESSOR
• Purpose: SUPPORTIVE CARE
• Intervention Model: PARALLEL
• Sponsor Type: OTHER
• Responsible Party: SPONSOR INVESTIGATOR
• PI Title: Attending physician

Study Record Dates

• First Submitted: June 7, 2016
• First Posted: June 15, 2016
• Study Start: July 1, 2016
• Primary Completion: February 3, 2018
• Study Completion: April 18, 2018
• Last Updated: April 16, 2019

Record last verified: 2019-04

Data Sharing

• IPD Sharing: Will not share

Locations

CN (1)